SCHEMBL7713134

SCHEMBL7713134

CC1(C)CCC(C)(C)c2cc(C#CC(O)c3ccc(C(=O)O)cc3)ccc21

nearest known ligand 0.74

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 11/20 0.74
▸ RARG P13631 11/20 0.74
▸ RARA P10276 8/20 0.74
▸ CYP26A1 O43174 2/20 0.74
▸ CYP3A4 P08684 2/20 0.74
▸ CRABP2 P29373 1/20 0.74
▸ RXRA P19793 11/20 0.64
▸ RXRB P28702 9/20 0.61
▸ CYP26B1 Q9NR63 1/20 0.59
▸ RXRG P48443 6/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6378967 0.94 RARB (0.68) RARBRARGRARACYP26A1CYP3A4
SCHEMBL3302926 0.85 RARB (1.00) RARBRARGRARACYP26A1CYP3A4
SCHEMBL29353973 0.85 RARB (1.00) RARBRARGRARACYP26A1CYP3A4
SCHEMBL7713109 0.84 CYP3A4 (0.66) RARBRARGRARACYP26A1CYP3A4
SCHEMBL6260318 0.82 RARB (0.50) RARBRARGRARACYP26A1CYP3A4
SCHEMBL1991598 0.82 RARB (0.50) RARBRARGRARACYP26A1CYP3A4
SCHEMBL6159273 0.82 RARB (0.50) RARBRARGRARACYP26A1CYP3A4
SCHEMBL7717546 0.82 RXRA (0.60) RARBRARGRARACYP26A1CYP3A4
SCHEMBL7714816 0.82 RARA (0.50) RARBRARGRARACYP26A1CYP3A4
SCHEMBL7709226 0.82 RARG (0.49) RARBRARGRARACYP26A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162445-A Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-19 — — US claimed
US-6001885-A INHIBITING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION IN KERATINOCYTES BY ADMINISTERING AT LEAST ONE RETINOID; USEFUL FOR TREATING DISEASES RELATING TO VEGF OVEREXPRESSION, SUCH AS PSORIASIS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 1999-12-14 — — US claimed
EP-0661258-B1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses CIRD GALDERMA (FR) 1998-04-08 — — EP claimed
EP-4623922-A2 ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA SNIPR Technologies Limited (GB) 2025-10-01 — — EP disclosed
US-6368608-B1 SKIN DISORDERS CENTRE INTERNATIONAL DE RECHERCHE DERMATOLOGIQUES GALDERMA (C.I.R.D.) (FR) 2002-04-09 — — US disclosed
US-6313162-B1 FOR USE IN HUMAN OR VETERINARY MEDICINE SUCH AS DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHHALMOLOGICAL DISORDERS; AND IN COSMETICS CENTRE INTERNATIONAL DE RECHERCHE DERMATOLOGIQUES GALDERMA (C.I.R.D.) GALDERMA (FR) 2001-11-06 — — US disclosed
US-6162445-A Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-19 — — US disclosed
US-6046220-A ADMINISTERING TO THE PATIENT A PROPYNYL OR DIENYL BIAROMATIC COMPOUND TO TREAT A SKIN DISORDER, INFLAMMATORY CONDITIONS, VISION DEFECTS, ALOPECIA, CARDIOVASCULAR DISORDER, CANCER OR PRECANCER AND INSULIN DEPENDANT DIABETES CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-04-04 — — US disclosed
US-6001885-A INHIBITING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION IN KERATINOCYTES BY ADMINISTERING AT LEAST ONE RETINOID; USEFUL FOR TREATING DISEASES RELATING TO VEGF OVEREXPRESSION, SUCH AS PSORIASIS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 1999-12-14 — — US disclosed
EP-0661258-B1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses CIRD GALDERMA (FR) 1998-04-08 — — EP disclosed
US-5716624-A USEFUL FOR TREATING DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, OPTHALMOLOGICAL DISORDERS, AS WELL AS MAMMALIAN SKIN AND HAIR CONDITIONS/DISORDERS C.I.R.D. GALDERMA (FR) 1998-02-10 — — US disclosed
EP-0661258-A1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-07-05 — — EP disclosed
Send feedback